Exane Derivatives’s Centene CNC Stock Holding History

Exane Derivatives’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.69K	Hold	20	–	–	﹤0.01%	455
2022 Q1	$1.68K	Hold	20	–	–	﹤0.01%	768
2021 Q4	$1.65K	Hold	20	–	–	﹤0.01%	674
2021 Q3	$1.25K	Hold	20	–	–	﹤0.01%	836
2021 Q2	$1.49K	Hold	20	–	–	﹤0.01%	840
2021 Q1	$1.28K	Hold	20	–	–	﹤0.01%	711
2020 Q4	$1.2K	Hold	20	–	–	﹤0.01%	665
2020 Q3	$1.17K	Hold	20	–	–	﹤0.01%	605
2020 Q2	$1.27K	Hold	20	–	–	﹤0.01%	541
2020 Q1	$1.19K	Hold	20	–	–	﹤0.01%	534
2019 Q4	$1.29K	Hold	20	–	–	﹤0.01%	526
2019 Q3	$865	Hold	20	–	–	﹤0.01%	547
2019 Q2	$1.05K	Hold	20	–	–	﹤0.01%	557
2019 Q1	$1.06K	Hold	20	–	–	﹤0.01%	495
2018 Q4	$1.15K	Buy	20 +6	+43%	+$402	﹤0.01%	562
2018 Q3	$1.01K	Buy	14 +2	+17%	+$139	﹤0.01%	539
2018 Q2	$747	Sell	12 -23,918	-100%	-$1.38M	﹤0.01%	550
2018 Q1	$1.2M	Buy	+23,930	New	+$1.25M	0.24%	108

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Politan Capital Management New York $255M AUM 62.37% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Exane Derivatives's CNC Position: Q2 2022 in Review

Exane Derivatives held its Centene (CNC) position steady in Q2 2022 at 20 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Exane Derivatives first reported a position in CNC in Q1 2018 and has held it in 18 quarters since. The position peaked at $1.2M in Q1 2018. 837 funds tracked by Wall St. Rank hold CNC as of Q2 2022.

Exane Derivatives held 20 shares of Centene worth $1.69K as of Q2 2022.
Exane Derivatives left its Centene share count unchanged in Q2 2022.
Centene made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #455 holding.
Exane Derivatives first reported a position in Centene in Q1 2018 and has held it in 18 quarters since.
Exane Derivatives's Centene position peaked at $1.2M in Q1 2018.
837 funds tracked by Wall St. Rank held Centene as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.